Pharmacological SOS1 inhibitor BI-3406 synergizes with BCR::ABL1 TKIs reducing leukemia stem cells and overcoming imatinib resistance in CML. [PDF]
García-Navas R +16 more
europepmc +1 more source
Vision loss as the first manifestation of isolated cns relapse in CML blast crisis during flumatinib maintenance therapy: A case report. [PDF]
Hong L, Mu J, Yang K, Zhuang H.
europepmc +1 more source
LEDGF/p75 Mediates Chemoresistance in Leukemia in a Context Dependent Manner. [PDF]
Akele TZ +5 more
europepmc +1 more source
Oxidative Phosphorylation and Fatty Acid Oxidation Are Central to Mitochondrial Metabolism Rewiring in CML Stem/Progenitor Cell Survival. [PDF]
Milenkovic J +6 more
europepmc +1 more source
Tyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries. [PDF]
Zhang L +11 more
europepmc +1 more source
Prolonged indolent clinical course in a high-risk chronic phase-CML patient without cytogenetic or molecular response: a case challenging established response paradigms. [PDF]
Longo E +8 more
europepmc +1 more source
Chronic Myeloid Leukaemia Developing During Long-Term Alectinib Therapy Successfully Managed With Concomitant Nilotinib: A Case Report. [PDF]
Ikematsu Y +3 more
europepmc +1 more source

